Page 6 - Preclinical Development News Today

ILC's Alfacyte product has potential to become a game-changing antiviral treatment in the ongoing global fight against Covid-19 Scottish biotech ICL Therapeutics has set its sights on a Series A round

Issuer: Immunic, Inc. / Key word(s): Conference Immunic to Participate in Investor and Scientific Conferences in May 26.04.2023 / 12:30 CET/CEST The issuer is solely responsible

/PRNewswire/ -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.coms offering. The report provides a comprehensive...

Needham (PRWEB) April 20, 2023 -- Bio-IT World today announced the 2023 Innovative Practices Awards winners. Six projects were honored; companies involved in

Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic potential in a broad range of TROP2- and... | April 17, 2023

Results support further investigation of two new ProTriTAC™ protease-activated T cell engager development candidates, with demonstrated therapeutic...

ALBANY, N.Y., April 13, 2023 /PRNewswire/ -- YDS Pharmatech, a computational drug discovery company specializing in induced proximity, today annou...

Dublin, April 07, 2023 (GLOBE NEWSWIRE) -- The "Global Preclinical Brain Imaging Market, By Imaging Type, By End User, Estimation & Forecast,...

/PRNewswire/ -- Annovis Bio, Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a clinical-stage drug platform company addressing neurodegenerative diseases, has...

Operator: Good afternoon and welcome to the PepGen Conference Call to discuss PepGens Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Developments.